NCT03322215 2024-03-08
PASIPHAE
Karolinska University Hospital
Phase 2 Terminated
Clinical Trials
3 trialsNCT04262804 2023-08-22
A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC
Zai Lab (Hong Kong), Ltd.
Phase 2 Unknown
NCT00532714 2011-12-30
Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC
National Cancer Center, Korea
Phase 2 Completed